SecBot SecBot
Home › SEC Filings

SEC Filing Analysis

10,000+ reports analyzed by SecBot AI · browse by date or by stock
TickerTypeSentimentImpactSummaryDate
XRX8-Kbearish6/10Xerox entered into an Exchange Support Agreement with holders of approximately 31.1% of its $556 million 5.500% Senior NOct 29, 2026
MA8-Kbullish6/10Mastercard reported Q3 2026 net revenue of $9.8B (+14% YoY) and GAAP diluted EPS of $5.28, both above consensus estimateOct 29, 2026
HTOPRESS-RELEASEbearish6/10H2O America commenced an underwritten public offering of 6.5 million equity units with a $325 million aggregate stated aOct 29, 2026
SPAIPRESS-RELEASEneutral3/10Safe Pro Group completed all milestones under a Phase I SBIR contract from AFWERX, developing an AI dataset for Foreign Oct 29, 2026
FSSPRESS-RELEASEneutral4/10The in-line results and modest revenue miss suggest limited near-term stock-moving catalyst from this release.Oct 29, 2026
PATKPRESS-RELEASEneutral5/10Patrick Industries reported Q3 2026 adjusted EPS of $1.03, beating the $0.99 consensus, while revenue of $975M was aboveOct 29, 2026
FSTR8-Kneutral5/10L.B. Foster Company, through its subsidiary CXT Incorporated, completed the acquisition of the operating assets of DulwoOct 29, 2026
HAFC8-Kneutral2/10Hanmi Financial Corp declared a Q4 2026 cash dividend of $0.28 per share, payable November 25, 2026 to holders of recordOct 29, 2026
JAGXDEFA14Abearish6/10Jaguar Health filed supplemental proxy materials ahead of its November 6, 2026 special meeting, disclosing that the boarOct 29, 2026
SATLPRESS-RELEASEbullish5/10Satellogic announced a three-year agreement with HEO to provide non-Earth imaging services, including a seven-figure minOct 29, 2026
MIRAPRESS-RELEASEneutral4/10MIRA Pharmaceuticals announced positive proof-of-concept results from a pilot mouse study of its oral obesity candidate Oct 29, 2026
PCSAPRESS-RELEASEbullish7/10Processa Pharmaceuticals announced FDA clearance of an IND for a Phase 2 study of VT-7208 in chronic spontaneous urticarOct 29, 2026
ITGRPRESS-RELEASEbearish5/10Integer Holdings reported Q3 2026 sales of $450M (down 3.9% YoY) and adjusted EPS of $1.34, missing the consensus estimaOct 29, 2026
CETXPRESS-RELEASEneutral4/10Cemtrex reported Q4 FY2026 revenue of $22.7M (+22% YoY) and swung to operating income of $1.4M from a $1.2M loss a year Oct 29, 2026
COLLPRESS-RELEASEneutral2/10Collegium Pharmaceutical announced an expanded multi-year partnership with Boston Legacy FC, a professional women's soccOct 29, 2026
SILC6-Kbullish6/10Silicom reported Q3 2026 revenue of $26.7M, up 71% YoY from $15.6M, and returned to non-GAAP profitability with net incoOct 29, 2026
OSK8-Kbearish6/10Oshkosh reported Q3 2026 GAAP EPS of $2.22 (down 27% YoY) and adjusted EPS of $2.41 (down 25% YoY), missing the consensuOct 29, 2026
UPBD8-Kmixed6/10Upbound Group reported Q3 2026 revenue of $1.146B (down 1.6% YoY) and non-GAAP diluted EPS of $1.01, exceeding the conseOct 29, 2026
ITGR8-Kbearish5/10Integer Holdings reported Q3 2026 results with sales of $450 million, down 3.9% YoY, and GAAP diluted EPS of $0.43, downOct 29, 2026
RITRF6-Kneutral5/10Reitar Logtech provided preliminary unaudited estimates for H1 FY2027 (six months ended September 30, 2026), projecting Oct 29, 2026
RFLPRESS-RELEASEneutral5/10Rafael Holdings reported Q4 FY2026 net loss of $9.2M ($0.18/share) vs $12.1M ($0.28/share) a year ago, with cash of $22.Oct 29, 2026
NMTCPRESS-RELEASEbullish6/10NeuroOne announced publication of initial clinical results for its OneRF Trigeminal Nerve Ablation System in Pain ManageOct 29, 2026
FMCC8-Kneutral5/10Freddie Mac reported Q3 2026 net income of $3.2 billion, up 17% year-over-year, driven by a 19% increase in net revenuesOct 29, 2026
STGW8-Kbullish6/10Stagwell reported Q3 2026 revenue of $816M (+10% YoY), net revenue of $664M (+8% YoY), GAAP diluted EPS of $0.07, and adOct 29, 2026
RAASY15-12Gneutral6/10Cloopen Group Holding Ltd filed Form 15 to terminate its SEC reporting obligations and deregister its securities, effectOct 29, 2026
IDA8-Kbullish6/10IDACORP reported Q3 2026 EPS of $2.73, beating the $2.51 consensus by 8.8%, on net income of $160.2M (up 28.7% YoY from Oct 29, 2026
NURSC 13G/Aneutral3/10KW Capital Partners Ltd. filed an amended Schedule 13G disclosing an increased passive stake in Nuran Wireless Inc. fromOct 29, 2026
SIRI8-Kneutral5/10SiriusXM reported Q3 2026 revenue of $2.15B, down slightly YoY, and GAAP diluted EPS of $0.78, down 7% YoY. Net income rOct 29, 2026
VRNO8-Kneutral5/10Verano reported Q3 2026 revenue of $212.4M, up 5% YoY from $202.8M, and a net loss of $(4.1)M versus a $(43.8)M loss in Oct 29, 2026
BDC8-Kbullish6/10Belden reported record Q3 2026 revenue of $966M (+38% YoY, +11% organic) and adjusted EPS of $2.26 (+15% YoY), in line wOct 29, 2026
« Previous Page 271 of 334 Next »